Concepedia

Iris C. Salaroglio

IC

29

Publications

1.3K

Citations

22

H-Index

2013

Active since

Affiliations

University of Turin(Current)

Azienda Ospedaliera Nazionale SS. Antonio e Biagio e Cesare Arrigo

Candiolo Cancer Institute

Weizmann Institute of Science

Institut Cochin

Iris C. Salaroglio is an author at University of Turin specializing in medicine, pharmacology, and oncology.

ORCID

Top concepts

Publications per year

2013–2024

29

Publications

29

PERK induces resistance to cell death elicited by endoplasmic reticulum stress and chemotherapy

Iris C. Salaroglio, Elisa Panada, Enrico Moiso et al. · Molecular Cancer · 2017 · 199 citations · Full text

Mitochondria-Targeted Doxorubicin: A New Therapeutic Strategy against Doxorubicin-Resistant Osteosarcoma

Ilaria Buondonno, Elena Gazzano, Sae Rin Jean et al. · Molecular Cancer Therapeutics · 2016 · 89 citations · Full text

, , +12

Folate-targeted liposomal nitrooxy-doxorubicin: An effective tool against P-glycoprotein-positive and folate receptor-positive tumors

Elena Gazzano, Barbara Rolando, Konstantin Chegaev et al. · Journal of Controlled Release · 2017 · 76 citations · Full text

, , +10

Temozolomide downregulates P-glycoprotein expression in glioblastoma stem cells by interfering with the Wnt3a/glycogen synthase-3 kinase/ -catenin pathway

Chiara Riganti, Iris C. Salaroglio, Valentina Caldera et al. · Neuro-Oncology · 2013 · 70 citations · Full text

Potential Diagnostic and Prognostic Role of Microenvironment in Malignant Pleural Mesothelioma

Iris C. Salaroglio, Joanna Kopecka, Francesca Napoli et al. · Journal of Thoracic Oncology · 2019 · 65 citations · Full text

Rows per page

1–5 of 29